

Author: Chiarenza A. Scarselli M. Novi F. Lempereur L. Bernardini R. Corsini G.U. Maggio R.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.433, Iss.1, 2001-12, pp. : 47-54
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Kato M. Ishida K. Chuma T. Abe K. Shigenaga T. Taguchi K. Miyatake T.
European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. :






Dopamine D1 receptor agonists as antiparkinson drugs
Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. :


Insulin receptor substrate polymorphisms and Type 2 diabetes mellitus
Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. :